Clinical Trial Update: The Artificial Saliva Spray Reduces Xerostomia in Diabetes Type II [NA]

View source ↗

Summary

A completed clinical trial evaluating an artificial saliva spray reported a reduction in xerostomia symptoms in individuals with type 2 diabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus
• Xerostomia

Drugs mentioned

• Artificial Saliva Spray

Snippet

Sponsor: Certmedica International GmbH | Conditions: Xerostomia Due to Hyposecretion of Salivary Gland, Diabetes Mellitus, Type 2 | NA | Status: COMPLETED